The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

The FDA sent out "100 cease-and-desist letters" to brands in response to what it says is "deceptive" pharma advertising - which could massively impact pharma's $7 billion U.S. national TV ad ...

Novo Nordisk has mandated a return to office work for all staff to speed up decision-making and improve market execution, ...

This Denmark-headquartered company underestimated demand for its anti-obesity treatment Wegovy when it launched in the U.S.

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company's focus on growth ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

In response to what it says is "deceptive" pharmaceutical ads, the FDA sent out "100 cease-and-desist letters" to brands - a move that could have massive impact on pharma's $7 billion U.S. national TV ...

The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company.

Novo Nordisk will lay off 9,000 employees worldwide as part of a restructuring plan, redirecting savings to diabetes and obesity drug growth.

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...